Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Amit Sanyal, MD: A Clinician’s Perspective

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Mar
26
Today In Oncology
Neoadjuvant GOLP in High-Risk Intrahepatic Cholangiocarcinoma
Gedatolisib-Based Regimens in HR-Positive HER2-Negative PIK3CA Wild-Type Advanced Breast Cancer
Hyperplasia and the Link Between Obesity and Cancer
Using AI to Differentiate Primary Lung Squamous Cell Carcinomas From Metastases
FDA Approves Relacorilant With Nab-Paclitaxel for Several Platinum-Resistant Gynecologic Cancers
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo